|
Prostate:
-
CTSU C90202: A Randomized, Double-Blind,
Placebo-Controlled Phase III Study of Early versus Standard
Zoledronic Acid to Prevent Skeletal Related Events in Men
with Prostate Cancer Metastatic to Bone.
-
CTSU C90203: A Randomized Phase III Study of
Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to
Radical Prostatectomy Versus Immediate Radical Prostatectomy
in Patients with High-Risk, Clinically Localized Prostate
Cancer
-
SWOG 0421: Phase III Study of Docetaxel and Atrasentan
Versus Docetaxel and Placebo for Patients with Advanced
Hormone Refractory Prostate
-
SWOG 0354: A Phase II Study of CNTO 328, A Monoclonal
Antibody Against Interleukin-6 (IL-6) in Patients with
Hormone Refractory Prostate Cancer
Bladder:
-
SWOG 0353: Phase II Study of Intravesical Gemcitabine in
Patients with Superficial Bladder Cancer Who Have Progressed
Despite Intravesical BCG
Renal Cell:
For more information on the above clinical
trials:
Cheryl Patz, RN, OCN, CCRC, 360.715.4133
Return to previous page
|